288) Key Points • Disease flare during pregnancy in patients |
289) Disease flare occurred in 25-80% of patien |
290) Most studies reported disease flare during pregnancy, and few re |
291) y peptide in conditions other than celiac disease, including collagen-induced arthri |
292) ing available to many people with chronic disease, including multiple sclerosis (MS) |
293) ge-varying relative risk profiles in nine diseases, including hypertension, skin can |
294) eted sequencing of variants and monogenic disease risks and returned to participants |
295) ntly associated with cardio-metabolic and disease risks in adults. |
296) ges to reduce obesity and noncommunicable disease risks. |
297) g focus on the role of diet in health and disease, we have only a limited understand |
298) To assess the heterogeneity of this disease, we recently conducted a clinical |
299) correlates of maternal mental health and disease, we will be better equipped to pre |
300) Canavan disease (CD) is a progressive, fatal neuro |
301) s been suggested to be involved in celiac disease (CD) pathogenesis by mediating int |
302) Chronic obstructive pulmonary disease (COPD) is the third leading cause |
303) iduals with chronic obstructive pulmonary disease (COPD). |
304) e responses involved in graft-versus-host disease (GVHD) and graft-versus-leukemia e |
305) d by the development of graft-versus-host disease (GVHD). |
306) predisposing factor in inflammatory bowel disease (IBD) and colitis-associated cance |
307) mplications, including inflammatory bowel diseases (IBD) and celiac disease, which w |
308) Non-alcoholic fatty liver disease (NAFLD) and its more severe form n |
309) style have made non-alcoholic fatty liver disease (NAFLD) one of the fastest growing |
310) patients affected by stroke, Parkinson's disease (PD), and multiple sclerosis (MS). |
311) tor and non-motor symptoms in Parkinson's disease (PD), there is limited evidence on |
312) s mellitus (type 1 and 2), chronic kidney disease (including dialysis), and chronic |
313) ng infective endocarditis, coronary heart disease (including myocardial infarction), |
314) ntrols were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dat |
315) We addressed this in 310 Alzheimer's Disease Neuroimaging Initiative (ADNI) par |
316) whereas relatively little is known about disease associations of SHANK1. |
317) Nicotine shows the most direct disease associations of these chemicals, f |
318) hip or sacroiliac joint affection of the disease but to other causes like pre-eclam |
319) , who are at presumed risk of more severe disease but who may also have decreased de |
320) nable them to increase control over their disease by better understanding and partic |
|